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Abstract
Background: Control of human African trypanosomiasis (sleeping sickness) in the Democratic Republic of Congo is based
on mass population active screening by mobile teams. Although generally considered a successful strategy, the community
participation rates in these screening activities and ensuing treatment remain low in the Kasai-Oriental province. A better
understanding of the reasons behind this observation is necessary to improve regional control activities.
Methods: Thirteen focus group discussions were held in five health zones of the Kasai-Oriental province to gain insights in
the regional perceptions regarding sleeping sickness and the national control programme’s activities.
Principal Findings: Sleeping sickness is well known among the population and is considered a serious and life-threatening
disease. The disease is acknowledged to have severe implications for the individual (e.g., persistence of manic periods and
trembling hands, even after treatment), at the family level (e.g., income loss, conflicts, separations) and for communities
(e.g., disruption of community life and activities). Several important barriers to screening and treatment were identified. Fear
of drug toxicity, lack of confidentiality during screening procedures, financial barriers and a lack of communication between
the mobile teams and local communities were described. Additionally, a number of regionally accepted prohibitions related
to sleeping sickness treatment were described that were found to be a strong impediment to disease screening and
treatment. These prohibitions, which do not seem to have a rational basis, have far-reaching socio-economic repercussions
and severely restrict the participation in day-to-day life.
Conclusions/Significance: A mobile screening calendar more adapted to the local conditions with more respect for privacy,
the use of less toxic drugs, and a better understanding of the origin as well as better communication about the prohibitions
related to treatment would facilitate higher participation rates among the Kasai-Oriental population in sleeping sickness
screening and treatment activities organized by the national HAT control programme.
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Introduction
Human African Trypanosomiasis (HAT) or African sleeping
sickness is a parasitic disease unique to sub-Saharan Africa. It is
caused by protozoa of the Trypanosoma Genus of which the species
T. brucei gambiense and T. brucei rhodesiense cause disease in humans.
According to WHO figures [1,2] the disease is present in 36 sub-
Saharan countries, where 60 million people are at risk of which
less than 4 million are under surveillance. In 2006 the annual
number of new cases was estimated to be between 50,000 and
70,000, but only a fraction of that number of cases is reported.
Between 1998 and 2009 the number of annually reported HAT
cases has dropped from 37,991 to 9,878 [2,3]. T. brucei gambiense
causes the chronic form of the disease which is endemic in central
and western Africa, while the acute form caused by T. brucei
rhodesiense is found in East-Africa [4].
HAT control strategies are based on early case detection and
treatment and vector control [1,5–7]. Active screening strategies
conducted by mobile teams which travel from village to village
have substantially lowered the case load in several African
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Democratic Republic of Congo (DRC), where T. brucei gambiense is
endemic, this control strategy has led to a considerable decrease in
case numbers throughout the whole country, albeit with a large
variability among the endemic provinces. In the North Equator
and Kinshasa provinces a significant decrease in prevalence was
observed. However, the number of cases detected in two other
provinces, Bandundu and Kasai-Oriental, has remained unabated
notwithstanding an increased screening effort [11,12]. Many
factors could explain this intervariability in HAT prevalence
among provinces which otherwise are all subject to the same HAT
control strategy. Amongst others, such factors could be related to a
low coverage of the population at risk, low community
participation rates in active screening and treatment activities, or
an inefficient management and coordination of the mobile teams.
Treatment failure could also play an important role, as studies
have shown significant treatment failure rates across the country’s
provinces, from 5 to 10% in Bandundu, to 25% in North Equator,
and possibly as high as 50% in Kasai-Oriental [13,14]. In 2007
adherence to treatment in DRC was at 91.6% [15], with very little
variation between endemic provinces. A recent analysis of the
operational effectiveness of HAT screening and treatment
activities in Kasai-Oriental (stagnation of infection rates) and
North Equator (decrease of infection rates) in 1998, 2001 and
2005 by Lumbala (unpublished, manuscript in preparation) shows
that low community participation rates in active screening
activities and coverage of the population at risk could well explain
the differences between these two provinces. While issues related
to the coverage of the population at risk lie with the management
and coordination of the national control programme’s activities
(availability of resources, control strategy), community participa-
tion rates reflect the level of health service utilization which can be
influenced by various social, economical and cultural factors.
It is thought that the low participation rate of the rural
population in the active screening activities is one of the main
reasons for the continued HAT transmission in Bandundu and
Kasai-Oriental. In a study on the effectiveness of active population
screening and treatment for sleeping sickness in DRC, Robays et
al [12] observed that the overall mean participation rate in the
provinces of Equateur, Bandundu and Kasai-Oriental was 74%.
However, important variability of the attendance rates between
villages, between mobile teams and between provinces were
observed. In Bandundu and Kasai-Oriental, participation rates as
low as 64% and 50% were respectively found.
The reasons for this low rate of community participation in
screening activities in these two provinces has been little investigated,
although a better understanding of relevant cultural and socio-
economic barriers could significantly improve the effectiveness of
HAT control programmes. Robays et al [16] showed for example that
in DRC’s Bandundu province the fear of drug toxicity, financial
barriers and the lack of confidentiality during screening were the most
important obstacles for participation in the HAT campaign in that
province. As a result of those findings, the DRC’s HAT control
program abolished the nominal user fee for screening. Although this
f e ew a sm i n i m a l ,i ts t i l lp r e s e n t e dah u r d l ef o rl a r g ef a m i l i e sw i t hn oo r
little income. These findings might be considered indicative for other
provinces of DRC, but care should be taken not to generalise as socio-
economic and cultural contexts are very heterogeneous across the
country. Therefore, this study aims to document in a qualitative
manner the economic and socio-cultural factors which may influence
community participation in active HAT screening and treatment
activities in the Kasai-Oriental province, where the disease puts not
only rural communities at risk but also a large group of workers who
are engaged in diamond mining activities. Additionally, as is illustrated
by the difference in local languages (Tshiluba in Kasai-Oriental,
Kikongo in Bandundu), the Kasai-Oriental and Bandundu provinces
differ distinctly on a cultural level, which may influence local disease
perceptions and health seeking behaviour habits.
Methods
Study area
We performed a transversal descriptive qualitative study using
the focus group discussion (FGD) technique in five health zones in
the Kasai-Oriental province of DRC: Miabi, Tshilenge, Tshiten-
gue, Kasansa and Mukumbi. Figure 1 shows the geographic
locations of these health zones.
These health zones were selected on the basis of their location in
a historic and currently active focus of HAT near the Kasai-
Oriental capital of Bakwanga (Kalelu- Lubilashi) which represents
almost 70% of the total number of reported cases in the province
[17]. Table 1 shows the HAT prevalence data for all five health
zones in 2005 and 2007. Along with the region’s linguistic and
cultural characteristics, the socio-economic setting in Kasai-
Oriental is very diverse due to the presence of a diamond industry
which employs many workers who live in encampments
surrounding the diamond mines. In Kasai-Oriental the main
populations at risk are diggers working in the diamond mines and
farmers, who represent the most active groups in the population.
Focus group discussions
The data collection took place in January 2008. Thirteen FGDs
were conducted. The focus groups were divided along three
categories: gender, geographic characteristics (i.e. worker camp or
village) and health zone. Table 2 shows the characteristics of each
of the FGDs performed in this study.
The number of FGDs conducted in the different health zones
reflects the ‘‘richness’’ of the information found in those health
zones. We continued to hold focus group discussions in a
particular health zone until data saturation was reached and no
new information was coming out of them. The FGDs were
Author Summary
Active screening strategies are common disease control
interventions in the context of poor and remote rural
communities with no direct access to healthcare facilities.
For such activities to be as effective as possible, it is
necessary that they are well adapted to local socio-
economic and cultural settings. Our aim was to gain
insight into the barriers communities in the Kasai-Oriental
province of the Democratic Republic of Congo experience
in relation to their participation in active screening
activities for African sleeping sickness. Participation rates
seem to be especially low in this province compared to
other endemic regions in the country. We found several
important factors to be in play, a number of which could
be addressed by adapting the operational procedures of
the mobile teams that perform the active screening
activities (e.g., improved confidentiality during the screen-
ing procedure). However, more profound considerations
were found in the form of regional beliefs related to the
treatment of the disease. Although not based on rational
grounds, these prohibitions seem to pose a significant
barrier in a person’s decision to seek diagnosis and
treatment. A better understanding of these prohibitions
and their origin could lead to improved participation rates
for sleeping sickness screening in Kasai-Oriental.
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to promote openness during the discussions, as women in general
do not speak freely in front of men in Kasai-Oriental. One of the
focus groups in Mukumbi was mixed because we were not able to
identify a minimum of six women willing to participate in an FGD
in that specific location.
The question guide used in the FGDs was pre-tested and fine
tuned in two focus group discussions performed in a health zone
not included in the study area. The quality of these discussions was
evaluated with the research team before finalizing the question
guide. The following topics were covered: general knowledge of
the disease; community practices regarding the disease; the
community’s attitude towards the mobile teams; the community’s
participation in screening and treatment activities; and commu-
nity’s expectations regarding HAT control services.
TheFGDsnumberedsixtonine participants who wereinvited by
the principal investigator (A.M.). They were selected at random
based on their availability and whether they gave consent for their
participation. Two exclusion criteria were used: (i) participants had
to be resident of the local community for at least 2 years (a definition
also used by the national HAT control programme in their
population surveillance data); (ii) community leaders such as
teachers, village chiefs and priests were excluded in order to avoid
them dominating the discussion dynamics. The FGDs took place in
a hut assigned bythecommunitychief forthis purpose.The average
duration of the discussions was 45 minutes. They were held in the
local language, Tshiluba. A local doctor and nurse, both native
Tshiluba speakers, weretrained tomoderate and observe theFGDs.
They switched roles for each discussion. Both had previously never
beeninvolvedinthe screeningactivitiesofthenationalHATcontrol
programme. Their training, which was conducted by A.M.,
consisted of a two-day course during which they were briefed on
the study objectives and taught how to conduct FGDs. Each
discussion was evaluated and discussed post-hoc by A.M. and the
two assistants. A.M. attended all the FGDs to supervise the process.
All discussions were fully recorded on a digital audio recorder.
Data analysis
The FGDs were transcribed and translated into French by the
two research assistants, who took turns in both tasks. A secretary
prepared the transcripts in Microsoft Word. A.M. revised all the
transcripts prior to analysis. QSR Nvivo8 was used to support the
data analysis and identify trends in the data. This software allows
researchers to organize and analyze complex and unstructured
datasets by fragmenting and categorizing data whilst keeping a link
with the source documents (transcripts of the FGDs in this case).
The analysis itself is an inductive process which allows themes to
emerge from the data. These themes are coded into categories
which are continuously refined throughout the analysis. Finally,
relationships between categories are created and inferences are
made. The analysis and its process were discussed with the co-
investigators.
The FGDs were coded, each element of the analysis
representing an intervention by a focus group discussion
participant. The codes were developed progressively and in an
inductive manner, allowing relevant themes to emerge from the
data. The coding book was discussed and refined with the co-
investigators to assure the significance of the analysis.
Ethical statement
The study protocol was approved by the thematic HAT
institutional review board (IRB) in DR Congo and the IRB of
the Institute of Tropical Medicine, Antwerp, Belgium. Local
community authorities were asked for permission to perform the
study in their villages. Focus group discussion participants were
informed about the voluntary nature of their participation.
Table 1. Prevalence data for the health zones included in the
study.






Source: 2005 and 2007 annual reports of the national control programme
division of Kasai-Oriental.
doi:10.1371/journal.pntd.0001467.t001
Table 2. Characteristics of the focus group discussions.
FGD nr Geographic characteristic Number of participants Gender Health zone
1 Diamond mine camp 7 Men Tshitengue
2 Diamond mine camp 9 Women Tshitengue
3 Village 8 Men Kansansa
4 Village 6 Women Kansansa
5 Village 9 Men Miabi
6 Village 7 Men Miabi
7 Village 9 Women Miabi
8 Village 8 Women Miabi
9 Village 9 Men Mukumbi
10 Diamond mine camp 7 Men Mukumbi
11 Diamond mine camp 7 Mixed Mukumbi
12 Village 8 Women Tshilenge
13 Village 6 Men Tshilenge
doi:10.1371/journal.pntd.0001467.t002
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prior to starting each of the focus group discussions. Anonymity of
the participants was guaranteed and no personal details were
recorded. Oral consent was obtained and audio recorded before
the start of each focus group discussion. Oral consent was
preferred since regional literacy levels are low. This procedure for
consent was approved by the IRB.
Results
In this section we will present the various aspects of community
perceptions related to HAT which were elaborated during the
FGDs. Data is presented in the form of quotes from the FGDs.
The quotes used in this section are illustrative of the sentiments
reflected in the FGDs and were selected on the basis of their
aptness and informative quality.
General knowledge and perceived symptoms
In general, sleeping sickness is well known in the region and is
considered an affliction which has been around for many
generations. In the local tongue it is referred to as ‘disama dya
tulu’, which literally translates to ‘sleeping sickness’. ‘‘Sleeping
sickness has been around for ages. We have heard people talking about it since
our childhood. It is an ancient disease.’’ [FG10] Nevertheless, whilst
many referred to specific cases from their direct environment
during the discussions -‘‘I know sick people. My mother has the disease
and so does my sister.’’ [FG4]- , not all participants had personally
been confronted with the disease in the past. ‘‘Well, I can’t really say
as I have never seen the disease. A typical example of a case? I haven’t seen one
yet.’’ [FG1] A number of people said they did not have any
‘scientific knowledge’ of the disease and were not completely at
ease with the medical rational approach adopted by the health
workers of the national control programme. ‘‘I know sleeping sickness
exists, but the knowledge about how to avoid it is given by doctors who ask
people to avoid this or that disease in this or that way.’’ [FG10]
When discussing the symptoms which they relate to the disease,
behavioural problems, sleep, tiredness, fever and headaches were
all commonly referred to in the FGDs. Behavioural problems and
the linked personality changes on the one hand, and irregular
sleeping patterns on the other, were considered the most tell-tale
signs of sleeping sickness. Women seemed to be more knowledge-
able about the symptoms and their relation to the disease than
men. This could be explained by the women’s traditional role as
caregiver. When a family member becomes sick, it is generally the
mother who accompanies them to the health services and who is
briefed by the health staff about the disease and how to take care
of the patient. Women are also more likely to participate in the
disease screening activities and thus to interact with health
workers, a trend which was also observed in other studies
[18,19]. The symptoms which are typical for the early stage of
the disease, such as fever, headaches and tiredness, seem to be
perceived less in the worker camps surrounding the diamond
mines than in the villages. When the disease is in its late
neurological stage the affected person is considered to be unaware
of his state. Rather, it is his entourage which identifies him as
abnormal and unable to take care of himself. ‘‘When a person has this
disease, she is not able to reason for herself. Only those who are at her side can
do it in her place.’’ [FG5]
Perceived severity and social consequences
Sleeping sickness is perceived as a severe illness since many
people are affected by it and many patients die. ‘‘Many people have
the disease, because we have seen with our own eyes how many people have died
of it. We can’t give an exact number, but many people have the sleeping
sickness.’’ [FG4] The consequences of sleeping sickness are
numerous and very visible within the communities, adding to
the perceived severity.
The disease has serious repercussions on the patient, the family
and the community. The high case fatality rate and the iatrogenic
deaths induced by the toxic drug melarsoprol are very well known.
Moreover, a large number of participants in our FGDs pointed
towards the neuropsychiatric sequelae in those surviving, such as
lunacy and trembling hands, which do not always regress after
treatment. ‘‘This disease turns people into idiots. In order to control him, he
needs to be restrained by force, even if he doesn’t agree with that. He doesn’t
want a child to come near him. If it does happen, he might kill the child. It’s the
same with tall people. Afterwards, when he has been treated, his spirit never
returns to normal. He remains confused and doesn’t know how to do things.’’
[FG13] It is considered shameful to be affected by the disease and
stigmatisation is common. This does however not imply a rejection
by the community, but rather signifies a shift of the patient’s place
in the community. In other words, the social role of the patient in
the community changes, together with the expectations, rights and
obligations which go along with that role.
At the level of the family the repercussions are for one part
socio-economic since when a family breadwinner becomes ill he
no longer is able to work and provide for the family’s needs. ‘‘The
concern is that the sick person could be working to support the family. But now
with him being sick, all those who depended on him share in his misfortune.’’
[FG5] The disease puts many additional strains on family ties and
marriages. When the man is sick for example, the woman is often
obliged to leave the house in order to avoid sexual relations with
her husband, which is locally considered to be strictly forbidden
for actual or recovering HAT patients. If it is the woman who is
sick, the man in general goes in search of another partner. This
can have drastic consequences for the family unit, as illustrated in
the following quote: ‘‘Women can also get the disease, in which case the
man doesn’t wait. He takes another woman into his house and puts his partner
out on the street together with the children, as they might be sorcerers, so they are
banished. We see them every day. We call them ‘the children of the market’’’
[FG6]. In some instances a case of HAT can also lead to family
conflicts caused by the search for a potential sorcerer considered to
be at the origin of the disease. ‘‘Sometimes they say that the sick person’s
mother, paternal aunt or uncle is at the source of the disease. They seem to forget
that the tse ´-tse ´ fly is where the disease comes from.’’ [FG13] On the
community level, an increase of HAT cases can have an impact on
the general development of the village. ‘‘One can say that many people
mainly work in the fields. When someone becomes sick, she no longer has the
strength to cultivate the fields. That has a negative impact on the village because
she no longer produces food for the village.’’ [FG5] In extreme cases this
can even lead to an implosion of the local community. ‘‘When many
people, or everybody, becomes sick, no work is done anymore. Many have
become idiots, others behave like madmen. The village is dead.’’ [FG4] Such
social and economic consequences can be very far reaching and
eventually lead to forced migration to other villages.
Perceived aetiology
In general, the vector of African sleeping sickness and its role in
disease transmission is well known in the communities. The tsetse
fly was elaborated upon in all FGDs and is locally known under
various names: dibudu, bibuiba and kabwibwibwa. ‘‘The fly bites,
she leaves behind this disease. She can be found in the villages, in the forests and
near water. This insect that we call ‘dibubu’’’ [FG2] However, several
other causes or modes of transmission were also stated. For
example, traditional beliefs and sorcery were sometimes referred to
when the spread of African sleeping sickness was discussed. ‘‘When
the adults of the village address solemn words against this disease, it
diminishes. So it is provoked by the realm of darkness.’’ [FG6] Some
Community Perceptions of HAT in DR Congo
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cultivated in the region—and pigs as a source of the diseases.
‘‘When we arrived here, they told us that the amaranth gives people the sleeping
sickness. When a person eats the amaranth, she will get the sleeping sickness.’’
[FG8] ‘‘I have already heard that the disease comes from the pigs here in the
village. They say that bad pigs carry this disease.’’ [FG7] Such beliefs are
likely grounded in the indirect role amaranths and pigs might play
in the diseases, transmission, since tsetse flies seem to be more
abundant in and around crop fields and animal pens.
Other discussants thought that the members of the mobile
teams played an important role in spreading the disease,
transmitting the disease while they perform the screening.
‘‘Observing how those who have the disease suffer, the population thinks that
the nurses of the team carry the disease and transmit it to you the moment you
stand in front of them.’’ [FG5] Finally, although rarely mentioned in
the focus group discussions, contagion was also elaborated as a
means by which the disease spreads. ‘‘Because it is a contagious disease.
If we eat together with him, we might get contaminated.’’ [FG1]
Prevention
In general, the communities talk about vector control activities
as the most important way of prevention. This further reflects their
general understanding of the tsetse fly’s role in the transmission of
the disease. ‘‘We take our machetes to cut down the trees, palms and others.
Bibuibua will be scared and take flight.’’ [FG3] ‘‘How the disease can be
avoided? By pouring medicine in the rivers and placing traps for the bibuibua.’’
[FG3] ‘‘That person should be educated and told to wear white clothes when
she goes into the jungle.’’ [FG6] On the other hand, there is a feeling
that prevention is in essence impossible because villagers cannot
abandon their livelihood activities, which take place in locations,
such as the fields, where the tsetse fly is found. ‘‘There is no way to
avoid contact since when we go to the fields the flies bite us.’’ [FG6] The
importance of raising awareness in communities is also referred to
as an efficient way of preventing infections. The mobile teams are
seen as an important channel in this respect. When they arrive in a
village and before they start the screening activities, the nurses of
the team give a lesson on how to avoid the disease. ‘‘They explain us
how we can avoid getting the disease, how the disease enters the village and why
we should avoid shabbiness around our houses.’’ [FG3]
Barriers to screening
The low attendance rates at the screening activities organised by
the national HAT control programme pose a significant problem.
When discussing the reasons for this observation during the FGDs,
six main barriers were identified: giving priority to occupational
activities; the toxicity of the drugs used in treatment; distrust
towards the nurses of the mobile teams; fear of lumbar punctures;
fear of unsolicited HIV/AIDS tests; and the lack of confidentiality
during the screening procedure itself.
The population wakes early in the morning to leave for the
diamond mines or crop fields. The mobile teams generally arrive
in the villages later in the morning, with little or no prior notice,
after most of the working populace have already left. Furthermore,
people tend to avoid screening as long as they consider themselves
to be healthy. Why risk being diagnosed and having to give up
your livelihood activities for a prolonged period of time for
treatment if you do not feel sick? ‘‘The people are afraid. Everyone
reasons that if they catch me with sleeping sickness, I will no longer be able to
do all my work. My activities won’t be able to take place anymore. So it is
better not to be tested as long as I don’t feel sick. Once I do, then I go to the
doctors. They will take care of me.’’ [FG12] This quote not only refers
to the inability to work during treatment, but also for a significant
period after treatment. The root of this logic lies in the regionally
accepted notion that one must adhere to a number of prohibitions
for six months after having been treated for HAT. Labouring is
such a prohibition and is therefore considered to be strictly
forbidden during the six-month rest period. These prohibitions are
further elaborated below in the section on barriers to treatment.
Drug toxicity is generally considered an important barrier to
participation in the active screening activities. Also in this context
people do not feel compelled to participate in the screening process
as long as they feel healthy and consider the risks of screening to
outweigh the benefits. ‘‘Many people have died, even the one who has only
been injected once. You see him die, and he wasn’t even sick. People are
frightened and think: ‘If I have myself tested, I might be giving up my activities
for nothing and I might even die.’’’ [FG3]
As was previously indicated when discussing the perceived
aetiology of HAT, there seems to be a degree of distrust from the
community towards the nurses of the mobile teams. In several
FGDs the latter were suspected of injecting the disease during the
screening procedure. This idea arises from the perception that
even people considered to be in good health are regularly
diagnosed with the disease by the mobile teams. ‘‘The people refuse to
have themselves tested because the nurses are going to inject them with the
disease. They leave the insect of sleep behind through their injections, making us
sick.’’ [FG7] Another example of this distrust which was voiced in
several FGDs is the belief that an HIV test is part of the HAT
screening procedure. There is a fear that one’s potentially positive
HIV status could be disclosed to the community, a risk people are
not willing to take given the consequences. If someone is identified
as HIV-positive, he or she becomes the focus of mockery and runs
the risk of being rejected by the community. ‘‘They refuse to present
themselves to the doctors because it is possible they are caught with AIDS. It is
not unlikely as AIDS is present here.’’ [FG9]
The screening procedure itself was also criticized in the
discussions. Especially the lack of confidentiality during the
screening activities was considered to be an important issue. The
procedure mostly takes place on a village square in plain sight of
all those queuing up for the screening. It is considered
embarrassing to be tested in public. Furthermore, people are
afraid their disease status would become public knowledge. ‘‘Me, I
feel shame about the possibility of being caught with this disease in public
because I would be mocked. Therefore, I don’t present myself for these tests.’’
[FG5] The lumbar puncture in open air, which is part of the
screening procedure, is also considered as a significant barrier.
‘‘Others are afraid of the syringe as it hurts in the spine. We are afraid of it.’’
[FG5]
Barriers to treatment
Cases confirmed by the mobile teams are referred to HAT
treatment centres. However, also here several important barriers
can be identified. The toxicity of the drugs, the financial
inaccessibility, the prohibitions related to the treatment, the
lacking geographic accessibility of the treatment centres, the sense
of feeling healthy notwithstanding a positive diagnosis, and the
fear of the regular lumbar punctures which are performed during
the follow-up of the treatment are all elements which influence
one’s decision to seek treatment after positive diagnosis by the
mobile teams.
Treatment of sleeping sickness in the region is free, but presents
significant indirect costs to the patient and his escorts, mainly
related to the travel to treatment centres on one hand, and
nourishment on the other. ‘‘When I was caught with the disease, I left the
village and left to Gandajika. I didn’t have any family there, I was
accompanied by my wife. When we ran out of food, we had to go back to our
village for food before returning to the treatment center. This was a huge
problem. That is why offering treatment in centres far away from the village
brings along many difficulties to the sick. How will they get to the centre? How
Community Perceptions of HAT in DR Congo
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[FG13] This opinion, especially regarding the financial repercus-
sions, was shared by many, though financial factors seemed to be
less of a barrier for those living in the encampments surrounding
the diamond mines.
One’s perceived health state is not only a factor in deciding
whether to participate in the screening activities, but also for the
next step, when a confirmed HAT case is referred to a treatment
centre. Some people diagnosed with sleeping sickness simply do
not feel sick and do not see the need to go through the long and
painful process of treatment. ‘‘They had diagnosed her with this disease.
Up to today she has decided not to receive treatment and she still is as she
always has been, in good health. So the people make mistakes with their tests,
and therefore we can’t have them done.’’ [FG5]
Of special interest are a number of generally accepted
prohibitions linked to the treatment of sleeping sickness. Patients
are expected to adhere to these prohibitions during a six month
resting period after treatment. The following prohibitions,
illustrated by the quotes in Table 3, were elaborated upon during
the FGDs: no walking in the sun; no warm meals and hot spices;
no alcohol consumption; no smoking; no heavy labour; and no
sexual relations. The social and economic implications of these
prohibitions form important barriers to HAT screening and
treatment activities. The patient’s chance of survival and the
probability of making a full recovery are perceived as being
directly linked to the degree to which the patients stick to the
prohibitions. Treatment failure and other complications are
blamed on the individual, reasoning they brought it upon
themselves by not adhering to the prohibitions. Because of their
importance, there is a strong element of social control involved, as
the patient’s entourage is mobilised to help him stick to the
prohibitions. The communities are very much aware of these
prohibitions. They were a recurring theme in most FGDs.
Although the cited six month rest period is an existing guideline
from the national HAT control programme [20], the specific
prohibitions mentioned in the FGDs are not.
Discussion
African sleeping sickness is well known and recognised as a
serious disease in the communities of Kasai-Oriental province. In
general the symptoms, vector, and treatment procedures for
sleeping sickness are well known amongst the population. Fear of
drug toxicity, lack of confidentiality during screening procedures
and financial barriers were all elaborated upon in the FGDs as
primary reasons for non-participation in the active screening
activities organised by the national control programme.
These findings are in line with a similar study conducted in the
province of Bandundu [16], although two additional important
barriers came forward in our focus group study.
The first is the apparent incompatibility between the itineraries
of the mobile screening teams and the population’s livelihood
activities. By the time the mobile screening teams arrive in the
village, many workers have already set out to the diamond mines
or crop fields. Part of this problem could be due to a lack of
communication between the mobile teams and the communities.
Improved planning of the screening activities to assure compat-
ibility with the local population’s habits would also be important in
this respect. Factors such as daily routines and seasonal variations
in the communities’ activities should therefore be taken into
account.
A second barrier which seems to be of particularly high
importance in Kasai-Oriental is the generally accepted belief that
a HAT patient must adhere to a number of prohibitions for a
period of six months after receiving treatment. These hold
important social and economic implications. For example, it is
forbidden to perform heavy labour for the first six months after
treatment. This prohibition makes it nearly impossible to make a
living during this period and signifies an important loss of income.
Additionally, by implying significant restrictions on participation
in everyday activities, the prohibitions also lead to a degree of
social exclusion and put a considerable amount of pressure on
family relationships. Strong social control regarding the prohibi-
tions is in place and victim blaming is common. When a person
becomes sick, suffers a relapse or dies during the rest period, this is
considered to be the result of non-adherence to the prohibitions.
Given the profound impact of the six month rest period and the
accompanying prohibitions, their observed role as a barrier to
active HAT screening and treatment activities in Kasai-Oriental is
not surprising. Even when a person is diagnosed with HAT they
will refuse to go to treatment centers up until the time they become
severely ill. For the national HAT control programme, a good
treatment is one that is administered within 10 days after
diagnosis. The problem is however that part of the population
refuses to even participate in active screening activities, as they
prefer not to know with certitude whether they have sleeping
sickness, thus ensuring they are able to avoid treatment and all the
prohibitions linked therewith. Although similar prohibitions were
reported in the Bandundu study by Robays et al [16], in our study
they seem to be a more profound element in the motivations of the
community’s actions as they constituted a recurring theme in
almost all focus group discussions.
Notwithstanding the important role the prohibitions seem to
take up in the communities’ perception regarding HAT, their
precise origin remains unclear. However, the fact that the
prohibitions do not seem to have a medical basis does not make
them any less significant as a barrier to HAT screening and
treatment. On the contrary, a better understanding of their origin
would be a first step in a process which could lead to a significantly
higher participation rate in the national programme’s screening
activities in Kasai-Oriental. Further in-depth research is therefore
necessary to document them. The focus of such research should
not only be on the communities, but should also investigate the
possible roles of the health workers in HAT treatment centers and
the mobile teams.
Table 3. Citations illustrating the prohibitions linked to the resting period after treatment.
‘‘ The major problem regarding sleeping sickness is the fact that people are asked not to have sexual relations with their wife, even when they have sexual desires. When the
patient has gone through the treatment and has returned home, during his ensuing rest period, he doesn’t respect the prohibition and he dies.’’ [FG6]
‘‘A patient in his rest period should not eat hot food, only cold food. He should not walk in the sun, drink alcohol, smoke, work or have sexual relations.’’ [FG10]
‘‘He may not eat hot things, stay under the sun, or stay in places where there is smoke. He must avoid things that have poison, and one should make sure he does not drink
alcohol. A person must be near at all times to keep an eye on him, to make sure he avoids all these things.’’ [FG10]
doi:10.1371/journal.pntd.0001467.t003
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naturalistic or holistic beliefs about illness and health. Maintaining a
form of natural balance is a central concept in such theories. Many
Hispanic, African, Arab and Asian cultures incorporate elements of
this basic idea in their understanding of disease. The Yin/Yang
theory used in Asian cultures is a well-know example of such an
approach. Another relatively common holistic framework used in
traditional understanding of health and illness is based on a hot/
cold dichotomy [21–23]. Some diseases are considered hot, whilst
others are considered cold. The same dichotomy is applied to
beverages, foods, herbs and medicines. Classification in either
category is not necessarily based on physical characteristics of the
item, but is more often according to their perceived effects on the
body or their association with natural elements. There is a strong
element of flexibility and subjectivity at play in the process of hot/
cold classification. Regional and cultural variations in classification
are therefore common. However, what is considered to be universal
in this mode of thought is the practice of perceiving disease as a hot-
cold imbalance which must be restored in order for the sick person
tobe cured.Asimilarlogicmightbeatworkbehindtheprohibitions
which forbid warm meals, hot spices and possibly alcohol. If
sleeping sickness is regarded as a hot disease, hot foods and
beverages would be considered to upset the patient’s hot/cold
balance after treatment rather than allowing it to be fully restored.
This imbalance, if not resolved, may then be perceived to lead to
complications, relapse or even death.
It appears from our FGDs that patients often remain with
neurological and psychiatric sequelae. Sleeping sickness is a
chronic disease that evolves in two stages. Stage 1, or the
hemolymphatic stage, is characterized by nonspecific symptoms
and can even remain asymptomatic [24]. The treatment for early
stage HAT is of low toxicity and recovery is complete.
Unfortunately at this stage the patient often does not seek care
as symptoms are mild or absent. When the patient does seek care,
the non-specific symptoms are often confounded with malaria—
which is also endemic in Kasai-Oriental—leading to misdiagnosis
and a delay in receiving correct treatment. Stage 2 HAT is
characterized by an infection of the nervous system which leads to
neurological and psychiatric disorders. It is often only at this stage
that a patient seeks care. The first-line treatment for second- stage
HAT in DRC at the time of this study was Melarsoprol, a toxic
organic compound of arsenic. Treatment with Melarsoprol can
cause severe side-effects such as arsenical encephalopathy in 5 to
10% of cases, which can lead to neurological damage and death
[25,26]. In Kasai-Oriental an important population at risk consists
of diamond diggers, an active portion of the population. These
workers are very concerned about their professional activities to
the point of ignoring their own health-related problems. As long as
they have the strength to continue working in the diamond mines,
they will not seek medical care, even if they are ill. Only when they
become severely sick and are no longer able to work do they go to
health centers. They therefore often present with well-advanced
HAT infections. Treatment at such a late stage is problematic and
mostly does not improve the neurological and psychiatric sequelae
caused by the disease, even after cure. Melarsoprol treatment
failure is high in Kasai-Oriental and—as was shown in this
study—is often accredited to non-compliance to the 6 month
resting period and the many prohibitions linked therewith.
Patients are blamed and are themselves held responsible if they
do not make a full recovery after treatment. Ultimately, the fear of
possibly failing to comply with these prohibitions becomes a
barrier to active HAT screening and treatment in itself.
The toxicity of the drugs used to treat HAT remains an
important barrier in a person’s decision to participate in the
national programme’s active screening activities. The adverse
effects of Melarsoprol are well documented [26], and the
communities are well aware of the risks associated to its use in
treatment. In November 2009 the WHO started rolling out a new
nifurtimox-eflornithine combination therapy (NECT) in DRC.
NECT has shown very high cure rates and low adverse effect rates.
Furthermore, it is relatively easy to administer, requiring only
fourteen infusions over the course of ten days. Although many
challenges remain [27], NECT has the potential to hugely
improve the level of HAT care which is delivered to communities.
However, it would be prudent to consider that it might take some
time before the implementation of NECT positively influences the
participation rates in the national programme’s active screening
activities. After all, perceptions and beliefs such as the fear of drug
toxicity are deep-rooted and do not change with the wind. The
legacy of melarsoprol will therefore most likely remain a barrier for
some time to come. If NECT is to live up to its full potential, it is
clear that communication and sustained community participatory
approaches have important roles to play in the activities of
national HAT control programmes, not just in the Democratic
Republic of Congo, but also in all other HAT endemic countries.
Additional socio-anthropological studies similar to the one
reported in this paper could offer valuable insights in this respect.
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